BioSpace News Archive

Drug Development

Biogen Halts Mid-Stage IPF Drug Trial Due to Safety Concerns

Days after the Cambridge-based company halted its BACE inhibitor program for Alzheimer’s disease, the company stopped another clinical trial in idiopathic pulmonary fibrosis due to safety reasons.

September 17, 2019
·
3 min read
·
Alex Keown
Career Advice

Follow These 6 Phone Interview Tips To Nail Any Interview

Are you worried about your first phone interview? Don’t worry, everyone gets through that phase. Follow these phone interview tips to nail your telephonic interview.

September 17, 2019
·
3 min read
·
Laura Brothers
Policy

Couple Charged for Stealing IP from Hospital to Launch Their Own Biotech in China

Late Monday the federal government charged the husband and wife team of Yu Zhou, 49, and Li Chen, 46, with theft of scientific trade secrets from the hospital that focused on exosomes and exosome isolation.

September 17, 2019
·
3 min read
·
Alex Keown
Business

Study Shows a Changing Attitude Regarding Lung Cancer Bias

A stigma remains around lung cancer and many people still regard the disease as something of a self-inflicted ailment. But that stigma is waning, new research conducted by the Inova Schar Cancer Institute and Genentech shows.

September 17, 2019
·
3 min read
·
Alex Keown
Drug Development

Acceleron Kills Mid-Stage FSHD Program Following Secondary Endpoint Failures

Acceleron Pharma said the Phase II FSHD trial assessing the efficacy of ACE-083 did not achieve functional secondary endpoints during the study.

September 17, 2019
·
2 min read
·
Alex Keown
Business

One Drop Teams with Bayer and Announces $40 Million Series B

The two companies also inked a commercial licensing deal for Bayer to use One Drop’s platform in Bayer’s worldwide bio-digital efforts in oncology, cardiovascular disease and women’s health.

September 17, 2019
·
3 min read
·
Mark Terry
Your Online Presence as a Professional

Professionals have unprecedented opportunities today to become known, and the biggest opportunity comes from building an online presence.

September 17, 2019
·
4 min read
·
Katharine Hansen, PhD
BioMidwest

Prostate Drug May be Useful for Treating Parkinson’s Disease

Collaborating researchers at the University of Iowa and Capital Medical University in Beijing, China, found that a drug used to treat enlarged prostate, terazosin, appears able to slow the progress of Parkinson’s disease.

September 17, 2019
·
3 min read
·
Mark Terry
Drug Development

Novartis’ Cosentyx Moves Closer to a 4th Indication with Positive Data in Spondyloarthritis Trial

The trial is still ongoing, but met its primary endpoint of ASAS40.

September 17, 2019
·
3 min read
·
Mark Terry
Business

Happify Health and Sanofi Sign Global Agreement to Bring Prescription Digital Mental Health Therapeutics to Individuals with Multiple Sclerosis

Happify Health announced it signed an agreement with global biopharmaceutical company Sanofi to advance the application of digital therapeutics to address key co-morbidities for individuals living with multiple sclerosis, including depression and anxiety.

September 17, 2019
·
5 min read